NASDAQ · Analyst Forecast

Exelixis, Inc. (EXEL) Stock Forecast & Price Target

$67.81 NASDAQ: EXEL Market Cap $17.04B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Exelixis, Inc. (EXEL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Exelixis, Inc., analysts forecast revenue rising from $2.32B in 2026 to $3.48B in 2031; the average estimate for 2031 earnings per share is $5.95; with published estimates ranging from $5.40 to $6.30; 12 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$67.81
Consensus targetThe average of the price targets analysts have published.$53.00
Median targetThe middle target, less affected by a single outlier.$52.00
Highest targetThe most optimistic published target.$60.00
Lowest targetThe most pessimistic published target.$49.00
Difference from priceHow far the consensus target sits from today’s price.-21.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026$2.16B$2.32B$2.43B11
2027$2.55B$2.56B$2.59B12
2028$2.63B$2.88B$3.00B12
2029$2.92B$3.31B$3.65B12
2030$3.41B$3.67B$3.84B6
2031$3.23B$3.48B$3.63B5

Earnings per share forecast

YearLowAverageHighAnalysts
2026$2.80$2.98$3.1211
2027$3.50$3.71$3.8812
2028$3.44$4.19$5.0612
2029$3.60$5.23$6.3112
2030$6.04$6.66$7.056
2031$5.40$5.95$6.305

Exelixis, Inc. (EXEL) forecast — frequently asked questions

What is the analyst price target for Exelixis, Inc.?

Analysts covering Exelixis, Inc. (EXEL) have a consensus price target of $53.00, 21.8% below the current price of $67.81. Published targets range from $49.00 to $60.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Exelixis, Inc.'s earnings?

The average analyst estimate for Exelixis, Inc. (EXEL) earnings per share in 2031 is 5.95, with individual estimates between 5.40 and 6.30.

How much revenue is Exelixis, Inc. expected to make?

Analysts forecast Exelixis, Inc. (EXEL) revenue of $3.48B in 2031, based on 5 published estimates.

How many analysts cover EXEL?

12 analysts contribute estimates for Exelixis, Inc. (EXEL). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.